250
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Microwave hyperthermia with X band flexible hyperthermia applicator for bone and joint cancer treatment

&
Pages 1285-1297 | Received 05 Aug 2021, Accepted 15 Dec 2021, Published online: 07 Jan 2022
 

Abstract

The microwave hyperthermia technique is proposed for bone and joint cancer with a flexible hyperthermia applicator operating in the X-band. The proposed approach consists of two steps. First, EM focus analysis is performed to optimize the phase value of antenna array elements’ excitation properties to concentrate the electromagnetic power at the tumor position while keeping the electromagnetic power level in healthy tissues at minimum values. Second, thermal analysis is performed by optimizing the amplitude value of the antenna elements’ excitation properties to achieve the required temperature at the tumor location. The proposed treatment technique is tested in a realistic simulation environment. The results obtained for different bone and joint models using the optimization technique for the excitation properties confirm the applicability of the proposed treatment method. In addition, the wideband frequency simulations show that frequencies around 10.4 GHz are the optimum values for treating bone and joint cancer.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.